China's coordinated tripartite medical reform: strategic balancing of interests among pharmaceuticals, healthcare, and health insurance
China has implemented the “Triple-Medical” reform, aiming to enhance the overall efficacy of the public healthcare system through deep integration and coordination among healthcare, pharmaceuticals, and health insurance regulator. This study utilizes game theory to analyze the strategic interplay an...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1591358/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850162346007199744 |
|---|---|
| author | Hanxiang Gong Hanxiang Gong Wenbo Wu Jifeng Li Baoling Wu Mengqi Gao Yajun Yang |
| author_facet | Hanxiang Gong Hanxiang Gong Wenbo Wu Jifeng Li Baoling Wu Mengqi Gao Yajun Yang |
| author_sort | Hanxiang Gong |
| collection | DOAJ |
| description | China has implemented the “Triple-Medical” reform, aiming to enhance the overall efficacy of the public healthcare system through deep integration and coordination among healthcare, pharmaceuticals, and health insurance regulator. This study utilizes game theory to analyze the strategic interplay and conflicts of interest among these three sectors within China's reform context, exploring the strategic choices and interactions that occur during the reform process. This study utilizes game theory to analyze the strategic interplay among pharmaceutical companies, healthcare institutions, and the health insurance regulator in China's healthcare reform. The model examines key variables and behaviors of each stakeholder, with MATLAB simulations analyzing evolutionarily stable strategies and parameter sensitivity. The findings reveal complex dynamic interactions among the strategies adopted by the various stakeholders within the healthcare reform, with the optimal strategies converging at the equilibrium point. Specifically, pharmaceutical companies seek maximum economic gains through drug pricing and quality control; healthcare institutions strive to enhance service efficiency and quality to meet patient needs; and medical insurance regulatory bodies play a crucial role in ensuring the efficiency and fairness of fund utilization. Such strategic alignments contribute to the stable operation of the healthcare system and maximize the interests of all parties involved. The study concludes that coordinated strategies among pharmaceutical companies, healthcare institutions, and health insurance regulator can achieve equilibrium and enhance the efficiency and equity of China's healthcare system. Changes in penalties for pharmaceutical companies, costs of medical service quality, and medical insurance regulatory costs critically influence healthcare reform, providing empirical support and a theoretical basis for effective policy-making. Refining policy adjustments and strategic optimizations can effectively coordinate the interests of all parties, propelling China's healthcare system toward greater efficiency and fairness. |
| format | Article |
| id | doaj-art-0ddef4fe346f443a969f9db4a865648e |
| institution | OA Journals |
| issn | 2296-2565 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj-art-0ddef4fe346f443a969f9db4a865648e2025-08-20T02:22:36ZengFrontiers Media S.A.Frontiers in Public Health2296-25652025-06-011310.3389/fpubh.2025.15913581591358China's coordinated tripartite medical reform: strategic balancing of interests among pharmaceuticals, healthcare, and health insuranceHanxiang Gong0Hanxiang Gong1Wenbo Wu2Jifeng Li3Baoling Wu4Mengqi Gao5Yajun Yang6The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou City, Guangdong, ChinaFaculty of Humanities and Social Sciences, Macau Polytechnic University, Macau, ChinaThe Second Affiliated Hospital, Guangzhou Medical University, Guangzhou City, Guangdong, ChinaThe Second Affiliated Hospital, Guangzhou Medical University, Guangzhou City, Guangdong, ChinaThe Second Affiliated Hospital, Guangzhou Medical University, Guangzhou City, Guangdong, ChinaThe Second Affiliated Hospital, Guangzhou Medical University, Guangzhou City, Guangdong, ChinaThe Second Affiliated Hospital, Guangzhou Medical University, Guangzhou City, Guangdong, ChinaChina has implemented the “Triple-Medical” reform, aiming to enhance the overall efficacy of the public healthcare system through deep integration and coordination among healthcare, pharmaceuticals, and health insurance regulator. This study utilizes game theory to analyze the strategic interplay and conflicts of interest among these three sectors within China's reform context, exploring the strategic choices and interactions that occur during the reform process. This study utilizes game theory to analyze the strategic interplay among pharmaceutical companies, healthcare institutions, and the health insurance regulator in China's healthcare reform. The model examines key variables and behaviors of each stakeholder, with MATLAB simulations analyzing evolutionarily stable strategies and parameter sensitivity. The findings reveal complex dynamic interactions among the strategies adopted by the various stakeholders within the healthcare reform, with the optimal strategies converging at the equilibrium point. Specifically, pharmaceutical companies seek maximum economic gains through drug pricing and quality control; healthcare institutions strive to enhance service efficiency and quality to meet patient needs; and medical insurance regulatory bodies play a crucial role in ensuring the efficiency and fairness of fund utilization. Such strategic alignments contribute to the stable operation of the healthcare system and maximize the interests of all parties involved. The study concludes that coordinated strategies among pharmaceutical companies, healthcare institutions, and health insurance regulator can achieve equilibrium and enhance the efficiency and equity of China's healthcare system. Changes in penalties for pharmaceutical companies, costs of medical service quality, and medical insurance regulatory costs critically influence healthcare reform, providing empirical support and a theoretical basis for effective policy-making. Refining policy adjustments and strategic optimizations can effectively coordinate the interests of all parties, propelling China's healthcare system toward greater efficiency and fairness.https://www.frontiersin.org/articles/10.3389/fpubh.2025.1591358/fullhealthcare reformevolutionary game theorypharmaceutical policymedical insurance regulationstakeholder coordination |
| spellingShingle | Hanxiang Gong Hanxiang Gong Wenbo Wu Jifeng Li Baoling Wu Mengqi Gao Yajun Yang China's coordinated tripartite medical reform: strategic balancing of interests among pharmaceuticals, healthcare, and health insurance Frontiers in Public Health healthcare reform evolutionary game theory pharmaceutical policy medical insurance regulation stakeholder coordination |
| title | China's coordinated tripartite medical reform: strategic balancing of interests among pharmaceuticals, healthcare, and health insurance |
| title_full | China's coordinated tripartite medical reform: strategic balancing of interests among pharmaceuticals, healthcare, and health insurance |
| title_fullStr | China's coordinated tripartite medical reform: strategic balancing of interests among pharmaceuticals, healthcare, and health insurance |
| title_full_unstemmed | China's coordinated tripartite medical reform: strategic balancing of interests among pharmaceuticals, healthcare, and health insurance |
| title_short | China's coordinated tripartite medical reform: strategic balancing of interests among pharmaceuticals, healthcare, and health insurance |
| title_sort | china s coordinated tripartite medical reform strategic balancing of interests among pharmaceuticals healthcare and health insurance |
| topic | healthcare reform evolutionary game theory pharmaceutical policy medical insurance regulation stakeholder coordination |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1591358/full |
| work_keys_str_mv | AT hanxianggong chinascoordinatedtripartitemedicalreformstrategicbalancingofinterestsamongpharmaceuticalshealthcareandhealthinsurance AT hanxianggong chinascoordinatedtripartitemedicalreformstrategicbalancingofinterestsamongpharmaceuticalshealthcareandhealthinsurance AT wenbowu chinascoordinatedtripartitemedicalreformstrategicbalancingofinterestsamongpharmaceuticalshealthcareandhealthinsurance AT jifengli chinascoordinatedtripartitemedicalreformstrategicbalancingofinterestsamongpharmaceuticalshealthcareandhealthinsurance AT baolingwu chinascoordinatedtripartitemedicalreformstrategicbalancingofinterestsamongpharmaceuticalshealthcareandhealthinsurance AT mengqigao chinascoordinatedtripartitemedicalreformstrategicbalancingofinterestsamongpharmaceuticalshealthcareandhealthinsurance AT yajunyang chinascoordinatedtripartitemedicalreformstrategicbalancingofinterestsamongpharmaceuticalshealthcareandhealthinsurance |